Table 2.
Factors | HR | Univariate analysis 95% CI | P | HR | Multivariate analysis 95% CI | P |
---|---|---|---|---|---|---|
Gender (female/male) | 1.439 | 0.776–2.667 | 0.248 | 1.710 | 0.914–3.201 | 0.093 |
Age (≥ 65/ < 65 years) | 1.561 | 0.796–3.060 | 0.195 | 1.705 | 0.861–3.374 | 0.126 |
Size of tumor (> 5 cm/ ≤ 5 cm) | 2.085 | 1.112–3.908 | 0.022* | 1.840 | 0.934–3.626 | 0.078 |
Lymph node metastasis (N1–3/N0) | 2.550 | 1.377–4.724 | 0.003* | 2.697 | 1.432–5.078 | 0.002* |
p-TNM stages (II + III + IV/I) | 2.950 | 1.501–5.800 | 0.002* | 2.393 | 1.196–4.788 | 0.014* |
PRC1 expression (high/low) | 5.853 | 2.285–14.997 | 0.000* | 4.766 | 1.840–12.346 | 0.001* |
HR hazard ration, 95% CI 95% confidence interval
* P < 0.05